Journal of Cardiovascular Pharmacology, 1533-4023

Journal

More filtering options
  1. 2019
  2. Exploration of Physiological and Pathophysiological Implications of miRNA-143 and miRNA-145 in Cerebral Arteries

    Christensen, S. T., Johansson, S. E., Warfvinge, K., Braun, T., Boettger, T., Lars Edvinsson & Haanes, K. A., 2019, In : Journal of Cardiovascular Pharmacology. 74, 5, p. 409-419 11 p.

    Research output: Contribution to journalArticle

  3. 2013
  4. 2012
  5. Levosimendan attenuates hypoxia-induced pulmonary hypertension in a porcine model.

    Wiklund, A., Kylhammar, D. & Göran Rådegran, 2012, In : Journal of Cardiovascular Pharmacology. 59, 5, p. 441-449

    Research output: Contribution to journalArticle

  6. 2010
  7. 2006
  8. 2005
  9. Triptans Induce Vasoconstriction of Human Arteries and Veins from the Thoracic Wall.

    Wackenfors, A., Jarvius, M., Richard Ingemansson, Lars Edvinsson & Malin Malmsjö, 2005, In : Journal of Cardiovascular Pharmacology. 45, 5, p. 476-484

    Research output: Contribution to journalArticle

  10. 2002
  11. P2 Receptor Expression Profiles in Human Vascular Smooth Muscle and Endothelial Cells.

    Wang, L., Karlsson, L., Moses, S., Hultgårdh-Nilsson, A., Andersson, M., Cedercrantz-Borna, C., Gudbjartsson, T., Jern, S. & David Erlinge, 2002, In : Journal of Cardiovascular Pharmacology. 40, 6, p. 841-853

    Research output: Contribution to journalArticle

  12. 1998
  13. Inhibition of angiotensin II-induced contraction by losartan in human coronary arteries

    Holmgren, A., Pantev, E., David Erlinge & Lars Edvinsson, 1998, In : Journal of Cardiovascular Pharmacology. 32, 4, p. 662-664

    Research output: Contribution to journalArticle

  14. 1996
  15. 1995
Previous 1 2 Next